[Myasthenia gravis and LE nephritis: problems of treatment with cholinesterase inhibitors during long-term dialysis (author's transl)].
D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000628:therapy*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000209:etiology; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000150:complications / Q000188:drug therapy*; D009393:Nephritis / Q000150:complications* / Q000628:therapy; D011729:Pyridostigmine Bromide / Q000008:administration & dosage*; D006435:Renal Dialysis
D011729:Pyridostigmine Bromide
Myasthenia gravis und Lupus-erythematodes-Nephritis. Problematik der Cholinesterasehemmer-Therapie bei Dauerdialyse.